Figure 4 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma

<p>Deregulated metabolism in response to tumor factors and LA. <b>A,</b> Using the RNA-seq data from <a href="#fig3" target="_blank">Fig. 3</a>, depicted here are the top 10 most significant GO terms for ”biological process” using all significantly u...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
1. autor: Angela Riedel (15130557) (author)
Kolejni autorzy: Moutaz Helal (15130560) (author), Luisa Pedro (15130563) (author), Jonathan J. Swietlik (15130566) (author), David Shorthouse (2733004) (author), Werner Schmitz (15130569) (author), Lisa Haas (15130572) (author), Timothy Young (15130575) (author), Ana S.H. da Costa (15130578) (author), Sarah Davidson (8254992) (author), Pranjali Bhandare (13789834) (author), Elmar Wolf (14952454) (author), Benjamin A. Hall (199856) (author), Christian Frezza (15130581) (author), Thordur Oskarsson (2313193) (author), Jacqueline D. Shields (14889899) (author)
Wydane: 2025
Hasła przedmiotowe:
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
_version_ 1849927631454076928
author Angela Riedel (15130557)
author2 Moutaz Helal (15130560)
Luisa Pedro (15130563)
Jonathan J. Swietlik (15130566)
David Shorthouse (2733004)
Werner Schmitz (15130569)
Lisa Haas (15130572)
Timothy Young (15130575)
Ana S.H. da Costa (15130578)
Sarah Davidson (8254992)
Pranjali Bhandare (13789834)
Elmar Wolf (14952454)
Benjamin A. Hall (199856)
Christian Frezza (15130581)
Thordur Oskarsson (2313193)
Jacqueline D. Shields (14889899)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Angela Riedel (15130557)
Moutaz Helal (15130560)
Luisa Pedro (15130563)
Jonathan J. Swietlik (15130566)
David Shorthouse (2733004)
Werner Schmitz (15130569)
Lisa Haas (15130572)
Timothy Young (15130575)
Ana S.H. da Costa (15130578)
Sarah Davidson (8254992)
Pranjali Bhandare (13789834)
Elmar Wolf (14952454)
Benjamin A. Hall (199856)
Christian Frezza (15130581)
Thordur Oskarsson (2313193)
Jacqueline D. Shields (14889899)
author_role author
dc.creator.none.fl_str_mv Angela Riedel (15130557)
Moutaz Helal (15130560)
Luisa Pedro (15130563)
Jonathan J. Swietlik (15130566)
David Shorthouse (2733004)
Werner Schmitz (15130569)
Lisa Haas (15130572)
Timothy Young (15130575)
Ana S.H. da Costa (15130578)
Sarah Davidson (8254992)
Pranjali Bhandare (13789834)
Elmar Wolf (14952454)
Benjamin A. Hall (199856)
Christian Frezza (15130581)
Thordur Oskarsson (2313193)
Jacqueline D. Shields (14889899)
dc.date.none.fl_str_mv 2025-11-25T13:44:07Z
dc.identifier.none.fl_str_mv 10.1158/2326-6066.30710353
dc.relation.none.fl_str_mv https://figshare.com/articles/figure/Figure_4_from_Tumor-Derived_Lactic_Acid_Modulates_Activation_and_Metabolic_Status_of_Draining_Lymph_Node_Stroma/30710353
dc.rights.none.fl_str_mv CC BY
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Cancer
Tumor Biology
Molecular and Cellular Biology
Immuno-oncology
Immunology
Immune responses to cancer
Metabolism
Mitochondrial function
Progression, Invasion & Metastasis
Metastasis
Tumor Microenvironment
Tumor-stromal cell interactions
dc.title.none.fl_str_mv Figure 4 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
dc.type.none.fl_str_mv Image
Figure
info:eu-repo/semantics/publishedVersion
image
description <p>Deregulated metabolism in response to tumor factors and LA. <b>A,</b> Using the RNA-seq data from <a href="#fig3" target="_blank">Fig. 3</a>, depicted here are the top 10 most significant GO terms for ”biological process” using all significantly upregulated genes in <i>in vitro</i> cultured FRCs treated for 4 days with B16.F10 TCM versus CCM. <b>B,</b> Heatmap displaying significant deregulated genes in TCM versus CCM (including data for 15 mmol/L LA vs. Veh – H<sub>2</sub>O) within ”fatty acid metabolism”. <b>C,</b> Significant intracellular (<i>P</i> < 0.05) metabolites in FRCs treated for 4 days with B16.F10 TCM versus CCM <i>in vitro</i>, measured by LC–MS and normalized on protein level. <b>D,</b> Significant intracellular (<i>P</i> < 0.05) metabolites in FRCs treated for 4 days with 15 mmol/L LA versus Veh – H<sub>2</sub>O <i>in vitro</i>, measured by LC–MS and normalized on cell number. <b>E,</b> Relative intracellular glutathione levels in FRCs treated for 4 days with CCM, B16.F10 TCM, 4T1 TCM, 15 mmol/L LA, or Veh – H<sub>2</sub>O <i>in vitro</i>, measured by LC–MS. <i>n</i> = 3 independent experiments. <b>F,</b> Relative abundance of citrate in brachial lymph nodes of female sham-treated (braLNs) and B16.F10 tumor-bearing C57BL/6 mice (B16 braTDLN), quantified by LC–MS. <i>n</i> = 7 independent experiments.<b>G,</b> Experimental set-up for labeling experiment. 4T1 tumor cells were cultured in <sup>13</sup>C<sub>6</sub>-glucose medium for 24 hours before medium was transferred to FRCs. In parallel, FRCs were cultured with <sup>13</sup>C<sub>3</sub> LA directly. In both cases, FRCs were treated for 4 days and metabolites measured by LC–MS. <b>H–J,</b><sup>13</sup>C-labeled metabolites identified by LC–MS using the set-up in <b>G</b>. <b>H,</b> glucose, glucose-6-P, lactate, and pyruvate. <b>I,</b> acetylcarnitine and <b>J,</b> citrate, aconitate, a-ketoglutarate, glutamate, succinate, fumarate, and malate. All <i>n</i> = 3 technical replicates. “M + n”, molecular mass plus the number of incorporated heavy carbons. Data are mean with SD. <b>K,</b> Diagram showing incorporation of lactate and pyruvate into downstream metabolites. Data are mean with SEM (unless stated differently). Significance (*, <i>P</i> < 0.05; **, <i>P</i> < 0.01; ***, <i>P</i> < 0.001; and ****, <i>P</i> < 0.0001) was determined by unpaired two-tailed <i>t</i> test. B16, B16.F10; h, hours; LA, lactic acid.</p>
eu_rights_str_mv openAccess
id Manara_108fc1983e5960462ed6fb4f950b86a9
identifier_str_mv 10.1158/2326-6066.30710353
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30710353
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY
spelling Figure 4 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node StromaAngela Riedel (15130557)Moutaz Helal (15130560)Luisa Pedro (15130563)Jonathan J. Swietlik (15130566)David Shorthouse (2733004)Werner Schmitz (15130569)Lisa Haas (15130572)Timothy Young (15130575)Ana S.H. da Costa (15130578)Sarah Davidson (8254992)Pranjali Bhandare (13789834)Elmar Wolf (14952454)Benjamin A. Hall (199856)Christian Frezza (15130581)Thordur Oskarsson (2313193)Jacqueline D. Shields (14889899)CancerTumor BiologyMolecular and Cellular BiologyImmuno-oncologyImmunologyImmune responses to cancerMetabolismMitochondrial functionProgression, Invasion & MetastasisMetastasisTumor MicroenvironmentTumor-stromal cell interactions<p>Deregulated metabolism in response to tumor factors and LA. <b>A,</b> Using the RNA-seq data from <a href="#fig3" target="_blank">Fig. 3</a>, depicted here are the top 10 most significant GO terms for ”biological process” using all significantly upregulated genes in <i>in vitro</i> cultured FRCs treated for 4 days with B16.F10 TCM versus CCM. <b>B,</b> Heatmap displaying significant deregulated genes in TCM versus CCM (including data for 15 mmol/L LA vs. Veh – H<sub>2</sub>O) within ”fatty acid metabolism”. <b>C,</b> Significant intracellular (<i>P</i> < 0.05) metabolites in FRCs treated for 4 days with B16.F10 TCM versus CCM <i>in vitro</i>, measured by LC–MS and normalized on protein level. <b>D,</b> Significant intracellular (<i>P</i> < 0.05) metabolites in FRCs treated for 4 days with 15 mmol/L LA versus Veh – H<sub>2</sub>O <i>in vitro</i>, measured by LC–MS and normalized on cell number. <b>E,</b> Relative intracellular glutathione levels in FRCs treated for 4 days with CCM, B16.F10 TCM, 4T1 TCM, 15 mmol/L LA, or Veh – H<sub>2</sub>O <i>in vitro</i>, measured by LC–MS. <i>n</i> = 3 independent experiments. <b>F,</b> Relative abundance of citrate in brachial lymph nodes of female sham-treated (braLNs) and B16.F10 tumor-bearing C57BL/6 mice (B16 braTDLN), quantified by LC–MS. <i>n</i> = 7 independent experiments.<b>G,</b> Experimental set-up for labeling experiment. 4T1 tumor cells were cultured in <sup>13</sup>C<sub>6</sub>-glucose medium for 24 hours before medium was transferred to FRCs. In parallel, FRCs were cultured with <sup>13</sup>C<sub>3</sub> LA directly. In both cases, FRCs were treated for 4 days and metabolites measured by LC–MS. <b>H–J,</b><sup>13</sup>C-labeled metabolites identified by LC–MS using the set-up in <b>G</b>. <b>H,</b> glucose, glucose-6-P, lactate, and pyruvate. <b>I,</b> acetylcarnitine and <b>J,</b> citrate, aconitate, a-ketoglutarate, glutamate, succinate, fumarate, and malate. All <i>n</i> = 3 technical replicates. “M + n”, molecular mass plus the number of incorporated heavy carbons. Data are mean with SD. <b>K,</b> Diagram showing incorporation of lactate and pyruvate into downstream metabolites. Data are mean with SEM (unless stated differently). Significance (*, <i>P</i> < 0.05; **, <i>P</i> < 0.01; ***, <i>P</i> < 0.001; and ****, <i>P</i> < 0.0001) was determined by unpaired two-tailed <i>t</i> test. B16, B16.F10; h, hours; LA, lactic acid.</p>2025-11-25T13:44:07ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/2326-6066.30710353https://figshare.com/articles/figure/Figure_4_from_Tumor-Derived_Lactic_Acid_Modulates_Activation_and_Metabolic_Status_of_Draining_Lymph_Node_Stroma/30710353CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307103532025-11-25T13:44:07Z
spellingShingle Figure 4 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
Angela Riedel (15130557)
Cancer
Tumor Biology
Molecular and Cellular Biology
Immuno-oncology
Immunology
Immune responses to cancer
Metabolism
Mitochondrial function
Progression, Invasion & Metastasis
Metastasis
Tumor Microenvironment
Tumor-stromal cell interactions
status_str publishedVersion
title Figure 4 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
title_full Figure 4 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
title_fullStr Figure 4 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
title_full_unstemmed Figure 4 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
title_short Figure 4 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
title_sort Figure 4 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
topic Cancer
Tumor Biology
Molecular and Cellular Biology
Immuno-oncology
Immunology
Immune responses to cancer
Metabolism
Mitochondrial function
Progression, Invasion & Metastasis
Metastasis
Tumor Microenvironment
Tumor-stromal cell interactions